U.S. Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules), By Mechanism (Controlled-, Immediate-release), By End-user, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology And Scope
                  1.1 Market Segmentation And Scope
                      1.1.1 Regional Scope
                      1.1.2 Estimates And Forecast Timeline.
                  1.2 Research Methodology
                  1.3 Information Procurement
                      1.3.1 Purchased Database
                      1.3.2 GVR’s Internal Database
                      1.3.3 Secondary Sources
                      1.3.4 Primary Research
                  1.4 Information/data Analysis
                      1.4.1 Information Analysis
                  1.5 Market Formulation & Visualization
                  1.6 Data Validation & Publishing
                  1.7 Market Definitions/scope
                  1.8 Model Details
                      1.8.1 Approach 1: Parent Market Analysis
                      1.8.2 Approach 2: Service/ Commodity Flow Analysis
                      1.8.3 Approach 3: Value-chain-based Sizing & Forecasting
                      1.8.4 Approach 4: Qfd Model Sizing & Forecasting
                  1.9 Market Formulation & Validation
                  1.10 List Of Secondary Sources
                  1.11 List Of Primary Sources
Chapter 2 Executive Summary
                  2.1 Market Snapshot
                  2.2 Segment Snapshot
                  2.3 Segment Snapshot
                  2.4 Competitive Landscape Snapshot
Chapter 3 U.S. Oral Solid Dosage Contract Manufacturing Market: Variables, Trends, & Scope
                  3.1 Market Lineage Outlook
                      3.1.1 Parent Market Outlook
                      3.1.2 Ancillary Market Outlook
                  3.2 U.S. Oral Solid Dosage Contract Manufacturing Dynamics
                  3.3 Market Dynamics
                      3.3.1 Market Driver Impact Analysis
                      3.3.2 Market Restraint Analysis
                  3.4 U.S. Oral Solid Dosage Contract Manufacturing Market: Analysis Tools
                      3.4.1 Porter’s Five Forces Analysis
                      3.4.2 PESTEL Analysis
                  3.5 COVID-19 Impact
                      3.5.1 Activities by Market Players
                      3.5.2 Long-Term Changes in The Pharmaceutical Contract Manufacturing Market
                  3.6 Analysis Pertaining to Oral Solid Dosage Packaging Types in the U.S. by Blisters vs. Bottles (Volume % Share, 2022)
                      3.6.1 Blister Packaging
                      3.6.2 Bottle Packaging
                      3.6.3 Types of Blister Packaging
                          3.6.3.1 Blister Packaging
                  3.7 Regulatory Landscape
                      3.7.1 U.S.
                      3.7.2 Europe
                      3.7.3 Rest Of The World
Chapter 4 U.S. Oral Solid Dosage Contract Manufacturing Market: Product Type Analysis
                  4.1 U.S. Oral Solid Dosage Contract Manufacturing Market by Product Type Segment: Key Takeaways
                  4.2 U.S. Oral Solid Dosage Contract Manufacturing Market: Product Type Movement Analysis
                  4.3 U.S. Oral Solid Dosage Contract Manufacturing Market Estimates & Forecast by Product Type (USD Million)
                      4.3.1 Tablets
                          4.3.1.1 Tablets Contract Manufacturing Market, 2018 - 2030 (USD Million)
                      4.3.2 Capsules
                          4.3.2.1 Capsules Contract Manufacturing Market, 2018 - 2030 (USD Million)
                      4.3.3 Powders
                          4.3.3.1 Powders Contract Manufacturing Market, 2018 - 2030 (USD Million)
                      4.3.4 Granules
                          4.3.4.1 Granules Contract Manufacturing Market, 2018 - 2030 (USD Million)
                      4.3.5 Others
                          4.3.5.1 Others Contract Manufacturing Market, 2018 - 2030 (USD Million)
Chapter 5 U.S. Oral Solid Dosage Contract Manufacturing Market: Mechanism Analysis
                  5.1 U.S. Oral Solid Dosage Contract Manufacturing Market by Mechanism Segment: Key Takeaways
                  5.2 U.S. Oral Solid Dosage Contract Manufacturing Market: Mechanism Movement Analysis
                  5.3 U.S. Oral Solid Dosage Contract Manufacturing Market Estimates & Forecast by Mechanism (USD Million)
                      5.3.1 Immediate Release
                          5.3.1.1 Immediate Release Contract Manufacturing Market, 2018 - 2030 (USD Million)
                      5.3.2 Delayed Release
                          5.3.2.1 Delayed Release Contract Manufacturing Market, 2018 - 2030 (USD Million)
                      5.3.3 Controlled Release
                          5.3.3.1 Controlled Release Contract Manufacturing Market, 2018 - 2030 (USD Million)
Chapter 6 U.S. Oral Solid Dosage Contract Manufacturing Market: End-user Analysis
                  6.1 U.S. Oral Solid Dosage Contract Manufacturing Market by End-user Segment: Key Takeaways
                  6.2 U.S. Oral Solid Dosage Contract Manufacturing Market: End-user Movement Analysis
                  6.3 U.S. Oral Solid Dosage Contract Manufacturing Market Estimates & Forecast by End User (USD Million)
                      6.3.1 Large-Size Companies
                          6.3.1.1 Large-Size Companies Contract Manufacturing Market, 2018 - 2030 (USD Million)
                      6.3.2 Medium & Small-Size Companies
                          6.3.2.1 Medium & Small Size Companies Contract Manufacturing Market, 2018 - 2030 (USD Million)
                      6.3.3 Others
                          6.3.3.1 Others Contract Manufacturing Market, 2018 - 2030 (USD Million)
Chapter 7 Country Estimates & Trend Analysis, 2018 - 2030 (USD Million)
                  7.1 U.S.
                      7.1.1 Key Country Dynamics
                      7.1.2 Competitive Scenario
                          7.1.2.1 U.S. Oral Solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Competitive Landscape
                  8.1 Company Categorization
                  8.2 Service Heat Map Analysis
                  8.3 U.S. Oral Solid Dosage Contract Manufacturing Company Market Share Analysis, 2022
                  8.4 Company Profiles
                      8.4.1 Catalent, Inc.
                          8.4.1.1 Participants’ Overview
                          8.4.1.2 Financial Performance
                          8.4.1.3 Product/Service Benchmarking
                          8.4.1.4 Strategy Initiatives
                      8.4.2 Lonza
                          8.4.2.1 Participants’ Overview
                          8.4.2.2 Financial Performance
                          8.4.2.3 Product/Service Benchmarking
                          8.4.2.4 Strategy Initiatives
                      8.4.3 AbbVie Inc.
                          8.4.3.1 Participants’ Overview
                          8.4.3.2 Financial Performance
                          8.4.3.3 Product/Service Benchmarking
                          8.4.3.4 Strategy Initiatives
                      8.4.4 Aenova Group
                          8.4.4.1 Participants’ Overview
                          8.4.4.2 Financial Performance
                          8.4.4.3 Product/Service Benchmarking
                          8.4.4.4 Strategy Initiatives
                      8.4.5 Adare Pharma Solutions
                      8.4.6 Boehringer Ingelheim International GmbH
                      8.4.7 Jubilant Pharmova Limited
                      8.4.8 Patheon Pharma Services
                      8.4.9 Recipharm AB.
                      8.4.10 Corden Pharma International
                      8.4.11 Siegfried Holding AG

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Oral Solid Dosage Contract Manufacturing Market by Product Type, 2018 - 2030 (USD Million)
Table 4 U.S. Oral Solid Dosage Contract Manufacturing Market by Mechanism, 2018 - 2030 (USD Million)
Table 5 U.S. Oral Solid Dosage Contract Manufacturing Market by End User, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. oral solid dosage contract manufacturing market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Data Analysis Models
Fig. 6 Market Formulation and Validation
Fig. 7 Data Validating & Publishing
Fig. 8 Parent market analysis
Fig. 9 Service/Commodity Flow Analysis
Fig. 10 Value-Chain-Based Sizing & Forecasting
Fig. 11 QFD model sizing & forecasting
Fig. 12 Market formulation & validation
Fig. 13 Market snapshot
Fig. 14 Segment snapshot
Fig. 15 Segment snapshot
Fig. 16 Competitive landscape snapshot
Fig. 17 Parent market outlook, 2022 (USD Million)
Fig. 18 Ancillary market outlook, 2022 (USD Million)
Fig. 19 U.S. oral solid dosage contract manufacturing market dynamics
Fig. 20 Biosimilar approval in the U.S. and EU per year (2016 - 2021)
Fig. 21 Porter’s five forces analysis
Fig. 22 U.S. oral solid dosage contract manufacturing market: PESTEL analysis
Fig. 23 Oral solid dosage packaging types in the U.S., 2022 (volume percentage share %)
Fig. 24 Oral solid dosage blister packaging types in the U.S., 2022 (volume percentage share %)
Fig. 25 Regulatory Landscape
Fig. 26 U.S. oral solid dosage contract manufacturing market: Product type outlook and key takeaways
Fig. 27 U.S. oral solid dosage contract manufacturing market: Product type movement analysis
Fig. 28 U.S. tablets contract manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 U. S. capsules contract manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 U. S. powders contract manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 U.S. granules contract manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 U. S. others contract manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 U.S. oral solid dosage contract manufacturing market: mechanism outlook and key takeaways
Fig. 34 U.S. oral solid dosage contract manufacturing market: mechanism movement analysis
Fig. 35 U.S. immediate release contract manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 U.S. delayed release contract manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 U.S. controlled release contract manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 U.S. oral solid dosage contract manufacturing market: end-user outlook and key takeaways
Fig. 39 U.S. oral solid dosage contract manufacturing market: End-user movement analysis
Fig. 40 Large-Size Companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Medium & small size companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 U.S. oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Key company categorization
Fig. 46 Service heat map analysis
Fig. 47 U.S. oral solid dosage contract manufacturing market share analysis, 2022